Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6OM0

Human ribosome nascent chain complex (PCSK9-RNC) stalled by a drug-like molecule with AP and PE tRNAs

This is a non-PDB format compatible entry.
Summary for 6OM0
Entry DOI10.2210/pdb6om0/pdb
EMDB information0526 0596 0597 0598 0599 0600 0601
Descriptor18S ribosomal RNA, 40S ribosomal protein S11, 40S ribosomal protein S15, ... (87 entities in total)
Functional Keywordsselective stalling, drug-like molecule, human ribosome nascent chain complex, ribosome
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains83
Total formula weight3175175.79
Authors
Li, W.,Cate, J.H.D. (deposition date: 2019-04-17, release date: 2019-06-19, Last modification date: 2024-11-13)
Primary citationLi, W.,Ward, F.R.,McClure, K.F.,Chang, S.T.,Montabana, E.,Liras, S.,Dullea, R.G.,Cate, J.H.D.
Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like molecule.
Nat.Struct.Mol.Biol., 26:501-509, 2019
Cited by
PubMed Abstract: The drug-like molecule PF-06446846 (PF846) binds the human ribosome and selectively blocks the translation of a small number of proteins by an unknown mechanism. In structures of PF846-stalled human ribosome nascent chain complexes, PF846 binds in the ribosome exit tunnel in a eukaryotic-specific pocket formed by 28S ribosomal RNA, and alters the path of the nascent polypeptide chain. PF846 arrests the translating ribosome in the rotated state of translocation, in which the peptidyl-transfer RNA 3'-CCA end is improperly docked in the peptidyl transferase center. Selections of messenger RNAs from mRNA libraries using translation extracts reveal that PF846 can stall translation elongation, arrest termination or even enhance translation, depending on nascent chain sequence context. These results illuminate how a small molecule selectively targets translation by the human ribosome, and provides a foundation for developing small molecules that modulate the production of proteins of therapeutic interest.
PubMed: 31160784
DOI: 10.1038/s41594-019-0236-8
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.1 Å)
Structure validation

238582

PDB entries from 2025-07-09

PDB statisticsPDBj update infoContact PDBjnumon